Why are rheumatologists in short supply?

Rheumatologist shortage is worsening for patients

Rheumatologists are increasingly scarce nationwide, driven by rising demand as more people live longer and autoimmune diseases become more common. The shortage matters because rheumatology care is specialized and often crucial for timely diagnosis and treatment of conditions that can damage joints and organs over time.

With fewer specialists available, patients can face delays in seeing an appropriate clinician, which can slow the start of disease-modifying therapy. That delay can translate into more ongoing symptoms and a higher risk of long-term complications for some autoimmune patients.

The underlying problem is less about a single hospital or region and more about a system-wide capacity gap: training and staffing have not kept pace with the growing number of people who need rheumatology expertise. When specialty access shrinks, primary care clinicians may be forced to cover larger caseloads, while patients seek care farther away or wait longer for appointments.

A nationwide shortage also tends to strain health systems’ scheduling and referral pathways. Even when patients eventually get in, the process may involve multiple visits and additional testing before treatment decisions can be finalized.

The news coverage highlights the core point for patients and policymakers: as autoimmune disease prevalence grows, specialist supply must expand too—otherwise, more people will experience the downstream effects of longer waits and harder-to-navigate care.

Bottom line

A growing number of older Americans means more autoimmune disease—and fewer rheumatologists to meet that rising need, leading to access problems across the country.